SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690709 (published erratum appears in Endocr Rev 15:261, 1994).
  • 2
    Stern PH 1990 Vitamin D and bone. Kidney Int 29:S17S21.
  • 3
    Zofkova I, Kancheva RL 1996 Effect of estrogen status on bone regulating hormones. Bone 19:227232.
  • 4
    Swolin D, Ohlsson C 1996 Growth hormone increases interleukin-6 produced by human osteoblast-like cells. J Clin Endocrinol Metab 81:43294333.
  • 5
    Bodo M, Venti G, Pezzetti F, Ardisia C, Antonica A, Carinci F, Becchetti E 1992 Interleukin-1α: Regulation of cellular proliferation and collagen synthesis in cultured human osteoblast-like cells. Cell Mol Biol 38:679686.
  • 6
    Riancho JA, Zarrabeitia MT, Olmos JM, Amado JA, Gonzalez-Macias J 1993 Effects of interleukin-4 on human osteoblast-like cells. Bone Miner 21:5361.
  • 7
    Edwards M, Sarma U, Flanagan AM 1998 Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones. Bone 22:325329.
  • 8
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA 1997 Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res 57:31943199.
  • 9
    Lader CS, Flanagan AM 1998 Prostaglandin E2, interleukin 1α, and tumor necrosis factor-α increase human osteoclast formation and bone resorption in vitro. Endocrinology 139:31573164.
  • 10
    Lee S, Solow-Cordero DE, Kessler E, Takahara K, Greenspan DS 1997 Transforming growth factor-β regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 272:1905919066.
  • 11
    Collins D, Woods A, Herd R, Blake G, Fogelman I, Wheeler M, Swaminathan R 1998 Insulin-like growth factor-I and bone mineral density. Bone 23:1316.
  • 12
    Linkhart TA, Mohan S, Baylink DJ 1996 Growth factors for bone growth and repair: IGF, TGF β and BMP. Bone 19:1S12S.
  • 13
    Baylink DJ, Finkelman RD, Mohan S 1993 Growth factors to stimulate bone formation. J Bon Miner Res 8:S565S572.
  • 14
    Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC 1991 Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17 β-estradiol and parathyroid hormone. Endocrinology 129:33133320.
  • 15
    Wu Y, Haugen JD, Zinsmeister AR, Kumar R 1997 1α,25-dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells. Biochem Biophys Res Commun 239:734739.
  • 16
    Wu Y, Craig TA, Lutz WH, Kumar R 1999 Identification of 1α,25-dihydroxyvitamin D3 response elements in the human transforming growth factor β2 gene. Biochemistry 38:26542660.
  • 17
    Centrella M, Horowitz MC, Wozney JM, McCarthy TL 1994 Transforming growth factor-β gene family members and bone. Endocr Rev 15:2739.
  • 18
    Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M 1986 Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem 261:1266512674.
  • 19
    Finkelman RD, Bell NH, Strong DD, Demers LM, Baylink DJ 1992 Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: Implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci U S A 89:1219012193.
  • 20
    Finkelman RD, Linkhart TA, Mohan S, Lau KH, Baylink DJ, Bell NH 1991 Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: Possible mechanism for impaired osteoinduction. Proc Natl Acad Sci U S A 88:36573660.
  • 21
    Turner RT, Farley J, Vandersteenhoven JJ, Epstein S, Bell NH, Baylink DJ 1988 Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats. J Clin Invest 82:212217.
  • 22
    Erlebacher A, Filvaroff EH, Ye JQ, Derynck R 1998 Osteoblastic responses to TGF-β during bone remodeling. Mol Biol Cell 9:19031918.
  • 23
    Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL 1997 Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541552.
  • 24
    Erlebacher A, Derynck R 1996 Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195210.
  • 25
    Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJ, Glasebrook AL, Termine JD 1996 Estrogen and raloxifene stimulate transforming growth factor-β3 gene expression in rat bone: A potential mechanism for estrogen- or raloxifene-mediated bone maintenance. Endocrinology 137:20752084.
  • 26
    Takasu H, Guo J, Bringhurst FR 1999 Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. J Bone Miner Res 14:1120.
  • 27
    Jouishomme H, Whitfield JF, Gagnon L, Maclean S, Isaacs R, Chakravarthy B, Durkin J, Neugebauer W, Willick G, Rixon RH 1994 Further definition of the protein kinase C activation domain of the parathyroid hormone. J Bone Miner Res 9:943949.
  • 28
    Martiny-Baron G, Kazanietz HM, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C 1993 Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:91949197.
  • 29
    Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Natio K, Toshioka T, Hidaka H 1990 Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:52675272.
  • 30
    Sugimoto T, Kano J, Fukase M, Fujita T 1992 Second messenger signaling in the regulation of the cytosolic pH and DNA synthesis by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: Role of Na+/H+ exchange. J Cell Physiol 152:2834.
  • 31
    Seitz PK, Zhu BT, Cooper CW 1992 Effect of transforming growth factor β on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells. J Bone Miner Res 7:541546.
  • 32
    Kim SJ, Glick A, Sporn MB, Roberts AB 1989 Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 264:402408.
  • 33
    Uht RM, Anderson CM, Webb P, Kushner PJ 1997 Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 138:29002908.
  • 34
    Veenstra TD, Fahnestock M, Kumar R 1998 An AP-1 site in the nerve growth factor promoter is essential for 1,25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Biochemistry 37:59885994.
  • 35
    Iida-Klein A, Varlotta V, Hahn TJ 1989 Protein kinase C activity in UMR-106-01 cells: effects of parathyroid hormone and insulin. J Bone Miner Res 4:767774.
  • 36
    Reid IR, Civitelli R, Halstead LR, Avioli LV, Hruska KA 1987 Parathyroid hormone acutely elevates intracellular calcium in osteoblast-like cells. Am J Physiol 252:E45E51 (published erratum appears in Am J Physiol 255:preceding E99, 1988).
  • 37
    Koe RC, Clohisy JC, Tyson DR, Pulumati MR, Cook TF, Partridge NC 1997 Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells. Calcif Tissue Int 61:5258.
  • 38
    Noma T, Glick AB, Geiser AG, O'Reilly MA, Miller J, Roberts AB, Sporn MB 1991 Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors 4:247255.
  • 39
    Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa J, Suda T, DeLuca HF 1998 Parathyroid hormone activation of the 25-hydroxyvitamin D3-1α-hydroxylase gene promoter. Proc Natl Acad Sci U S A 95:13871391.
  • 40
    Evans DB, Hipskind RA, Bilbe G 1996 Analysis of signaling pathways used by parathyroid hormone to activate the c-fos gene in human SaOS2 osteoblast-like cells. J Bone Miner Res 11:10661074.